Table 4.
Bivariate
|
Multivariate
|
|||
---|---|---|---|---|
Variable | Hazard ratio | 95% CI | Hazard ratio | 95% CI |
HIV status | ||||
Uninfected | Reference | |||
Infected | 1.12 | 0.60-2.12 | 1.12 | 0.57-2.20 |
Disease stage | ||||
I (IA, IB) | Reference | |||
II (IIA, IIB) | 2.21 | 0.67-7.32 | 1.65 | 0.47-5.79 |
III (IIIA, IIIB)/IV | 2.87 | 0.84-9.81 | 2.32 | 0.65-7.54 |
Age (y) | ||||
<40 | Reference | |||
40-59 | 1.48 | 0.74-2.96 | 2.17* | 1.05-4.47* |
>60 | 1.22 | 0.45-3.29 | 2.46 | 0.80-7.54 |
Baseline hemoglobin level (g/dL) | ||||
≥10 | Reference | |||
>10* | 0.39* | 0.22-0.70* | 0.37* | 0.19-0.72* |
No. of chemotherapy cycles | ||||
1 | 2.51* | 1.12-5.61* | 2.25 | 0.99-5.13 |
2 | 0.86 | 0.30-2.49 | 0.67 | 0.22-2.06 |
3 | 1.08 | 0.52-2.27 | 1.10 | 0.52-2.35 |
≥4* | Reference | |||
Final EQD2 dose (Gy) | ||||
<75 | Reference | |||
≥75* | 0.56* | 0.31-1.01* | 0.52* | 0.27-0.97* |
Abbreviation: CI = confidence interval. Other abbreviation as in Table 2.
Statistically significant.